Nobuhiro Inatomi

3.0k total citations
73 papers, 2.5k citations indexed

About

Nobuhiro Inatomi is a scholar working on Surgery, Gastroenterology and Molecular Biology. According to data from OpenAlex, Nobuhiro Inatomi has authored 73 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 33 papers in Gastroenterology and 30 papers in Molecular Biology. Recurrent topics in Nobuhiro Inatomi's work include Helicobacter pylori-related gastroenterology studies (33 papers), Gastroesophageal reflux and treatments (21 papers) and Gastrointestinal motility and disorders (12 papers). Nobuhiro Inatomi is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (33 papers), Gastroesophageal reflux and treatments (21 papers) and Gastrointestinal motility and disorders (12 papers). Nobuhiro Inatomi collaborates with scholars based in Japan and United States. Nobuhiro Inatomi's co-authors include Jun Matsukawa, Haruyuki Nishida, Masahiro Kajino, Zen Itoh, Yasunobu Hori, Satoshi Ōmura, Hideaki Nagaya, Shogo Marui, Hiroshi Satoh and Kazuo Tsuzuki and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Biochemical and Biophysical Research Communications.

In The Last Decade

Nobuhiro Inatomi

70 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuhiro Inatomi Japan 27 1.1k 1.0k 592 380 249 73 2.5k
Enar Carlsson Sweden 29 1.7k 1.6× 954 0.9× 1.4k 2.4× 404 1.1× 417 1.7× 81 4.2k
André Robert United States 22 2.1k 1.9× 639 0.6× 742 1.3× 348 0.9× 312 1.3× 47 4.1k
Horace W. Davenport United States 22 1.5k 1.4× 986 1.0× 456 0.8× 294 0.8× 329 1.3× 75 3.0k
Steven J. Shiff United States 22 1.1k 1.0× 1.1k 1.1× 630 1.1× 166 0.4× 282 1.1× 68 3.1k
B. M. Peskar Germany 34 1.4k 1.3× 366 0.4× 771 1.3× 259 0.7× 737 3.0× 95 4.2k
James E. Nezamis United States 21 1.9k 1.7× 603 0.6× 686 1.2× 279 0.7× 292 1.2× 58 3.8k
Joseph Chang United States 24 392 0.4× 264 0.3× 905 1.5× 111 0.3× 342 1.4× 73 2.4k
N. K. Boughton-Smith United Kingdom 25 601 0.5× 164 0.2× 483 0.8× 172 0.5× 1.3k 5.1× 40 2.9k
Maria Notarnicola Italy 34 619 0.6× 166 0.2× 1.3k 2.2× 148 0.4× 475 1.9× 152 3.6k
D. Aures United States 22 692 0.6× 254 0.2× 641 1.1× 141 0.4× 187 0.8× 51 1.8k

Countries citing papers authored by Nobuhiro Inatomi

Since Specialization
Citations

This map shows the geographic impact of Nobuhiro Inatomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Inatomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Inatomi more than expected).

Fields of papers citing papers by Nobuhiro Inatomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Inatomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Inatomi. The network helps show where Nobuhiro Inatomi may publish in the future.

Co-authorship network of co-authors of Nobuhiro Inatomi

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Inatomi. A scholar is included among the top collaborators of Nobuhiro Inatomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Inatomi. Nobuhiro Inatomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otake, Kazuyoshi, Yuuichi Sakurai, Haruyuki Nishida, et al.. (2016). Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438). Advances in Therapy. 33(7). 1140–1157. 71 indexed citations
2.
Matsukawa, Jun, Nobuhiro Inatomi, & Kazuyoshi Otake. (2015). Pharmacological and clinical profiles of a novel potassium-competitive acid blocker, vonoprazan fumarate (Takecab<sup>®</sup> 10 mg and 20 mg). Folia Pharmacologica Japonica. 146(5). 275–282. 2 indexed citations
3.
Marcus, Elizabeth A., Nobuhiro Inatomi, Glenn T. Nagami, George Sachs, & David R. Scott. (2012). The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin. Alimentary Pharmacology & Therapeutics. 36(10). 972–979. 80 indexed citations
4.
Kondo, Mitsuyo, et al.. (2011). High-Throughput Screening of Potassium-Competitive Acid Blockers. SLAS DISCOVERY. 17(2). 177–182. 24 indexed citations
5.
Shin, Jai Moo, Nobuhiro Inatomi, Keith Munson, et al.. (2011). Characterization of a Novel Potassium-Competitive Acid Blocker of the Gastric H,K-ATPase, 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438). Journal of Pharmacology and Experimental Therapeutics. 339(2). 412–420. 116 indexed citations
6.
Inatomi, Nobuhiro, et al.. (2008). Pharmacological and clinical profile of lansoprazole (Takepron®IV injection 30 mg). Folia Pharmacologica Japonica. 131(2). 149–156. 2 indexed citations
7.
Nagaya, Hideaki, et al.. (2005). Novelty Stress Increases Fecal Pellet Output in Mongolian Gerbils: Effects of Several Drugs. Journal of Pharmacological Sciences. 98(4). 411–418. 16 indexed citations
8.
Nagaya, Hideaki, et al.. (2001). Effects of TAK-637, a Novel Neurokinin-1 Receptor Antagonist, on Colonic Function in Vivo. Journal of Pharmacology and Experimental Therapeutics. 298(2). 559–564. 30 indexed citations
9.
Satoh, Hiroshi, Akio Shino, Fumihiko Sato, et al.. (1997). Role of Endogenous Basic Fibroblast Growth Factor in the Healing of Gastric Ulcers in Rats.. The Japanese Journal of Pharmacology. 73(1). 59–71. 35 indexed citations
10.
Satoh, Hiroshi, Fumihiko Sato, Shoichi Asano, et al.. (1997). Role of Endogenous Basic Fibroblast Growth Factor in the Healing of Gastric Ulcers in Rats. The Japanese Journal of Pharmacology. 73(1). 59–71. 10 indexed citations
11.
Inatomi, Nobuhiro, et al.. (1996). Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion.. Folia Pharmacologica Japonica. 108(6). 333–343. 2 indexed citations
12.
Funabashi, Yasunori, Nobuhiro Inatomi, SEIICHI TANIDA, et al.. (1996). Microbial Conversion of EM574 and EM523, Gastrointestinal Motor Stimulating Agents.. The Journal of Antibiotics. 49(8). 802–810. 3 indexed citations
13.
Funabashi, Yasunori, Nobuhiro Inatomi, Shigeharu Tanayama, et al.. (1996). Bioactive Metabolites of EM574 and EM523, Erythromycin Derivatives Having Strong Gastrointestinal Motor Stimulating Activity.. The Journal of Antibiotics. 49(8). 794–801. 8 indexed citations
14.
Inatomi, Nobuhiro, Takashi Satoh, Hiroshi Satoh, Zen Itoh, & Satoshi Ōmura. (1993). Comparison of the Motor-Stimulating Action of EM523, an Erythromycin Derivative, and Prostaglandin F2 in Conscious Dogs. The Japanese Journal of Pharmacology. 63(2). 209–217. 5 indexed citations
15.
Satoh, Takashi, Nobuhiro Inatomi, Hiroshi Satoh, et al.. (1990). EM-523, an erythromycin derivative, and motilin show similar contractile activity in isolated rabbit intestine.. Journal of Pharmacology and Experimental Therapeutics. 254(3). 940–944. 39 indexed citations
16.
Ōmura, Satoshi, Kazuo Tsuzuki, Toshiaki Sunazuka, et al.. (1987). Macrolides with gastrointestinal motor stimulating activity. Journal of Medicinal Chemistry. 30(11). 1941–1943. 148 indexed citations
17.
Satoh, Hiroshi, et al.. (1986). Antisecretory activity of AG-1749, a proton pump inhibitor. The Japanese Journal of Pharmacology. 40. 226–226. 7 indexed citations
18.
Satoh, Hiroshi, et al.. (1986). Spizofurone, a new anti-ulcer agent, increases alkaline secretion in isolated bullfrog duodenal mucosa. European Journal of Pharmacology. 124(1-2). 149–155. 1 indexed citations
19.
Inatomi, Nobuhiro, et al.. (1985). Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.. PubMed. 35(10). 1553–9. 3 indexed citations
20.
Inatomi, Nobuhiro, Hiroshi Satoh, Hideaki Nagaya, & Yoshitaka Maki. (1985). Spizofurone (AG-629) increases gastric mucosal blood flow in dogs: A possible mechanism of its anti-ulcer effect. European Journal of Pharmacology. 110(3). 343–350. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enar Carlsson Breakdown of academic impact, for papers by André Robert Breakdown of academic impact, for papers by Horace W. Davenport Breakdown of academic impact, for papers by Steven J. Shiff Breakdown of academic impact, for papers by B. M. Peskar Breakdown of academic impact, for papers by James E. Nezamis Breakdown of academic impact, for papers by Joseph Chang Breakdown of academic impact, for papers by N. K. Boughton-Smith Breakdown of academic impact, for papers by Maria Notarnicola Breakdown of academic impact, for papers by D. Aures
Rankless by CCL
2026